At the core of Astrea Bioseparations’ chromatography resin portfolio is the PuraBead® base matrix, an engineered bead platform manufactured using our proprietary atomization technology. Designed to deliver strength, consistency, and versatility, PuraBead® forms the foundation of our ion exchange (IEX), hydrophobic interaction (HIC), affinity, and mixed-mode chromatography resins.

PuraBead® provides high mechanical strength, low backpressure, and strong flow properties, supporting reliable performance in downstream bioprocessing from early-stage development through large-scale GMP manufacturing. Unlike conventional bead technologies, PuraBead® is produced using a solvent-free, more sustainable manufacturing process that reduces waste while maintaining batch-to-batch reproducibility and robustness for critical biopharmaceutical purification applications.

With a long track record in the industry, PuraBead® underpins multiple FDA-approved therapeutics, reflecting its reliability and regulatory acceptance. Our expertise also extends to long-standing partnerships, including more than a decade of collaboration manufacturing Thermo Fisher Scientific’s CaptureSelect® range on our PuraBead® base matrix, supporting advanced affinity purification workflows used globally.

Central to our chromatography technology, PuraBead® continues to enable the development and manufacture of life-changing therapies, delivering sustainable, scalable, and industry-proven performance.